Syrris Announce new West Coast Office
News Mar 15, 2007
Syrris has announced the expansion of its US sales and customer service team with the opening of a West Coast office in La Jolla, CA. The office will provide further support for its modular flow chemistry and synthesis products and compliment its established sister office in Boston, MA. Both East and West coast sites promise to broaden Syrris’s US support network.
Syrris is known for its technologies and expanding product lines, delivering high performance systems to major pharma companies and academic institutions worldwide. Following their 2006 launch, the modular FRX flow chemistry system and the atlas multipurpose synthesis tool have gone from strength to strength.
Syrris’s US-based Commercial Director, Richard Gray said “This an exciting phase of development for Syrris. The company is growing fast and our customer base is rapidly expanding, so we have not only increased our distribution capacity worldwide but also want to make sure our customers have full technical support. With our UK and US offices in place we feel we can continue to provide the high quality service for which we are known.”
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Bone Cancer Drug Targets Tumors, Spares Other OrgansNews
A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018